Chiesi Türkiye, headquartered in Istanbul, operates with more than 16 years of experience. Also Chiesi Türkiye is part of a global group of companies that meet high social and environmental impact standards as a certified benefit company (B Corp) since 2022.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.
Angelini Pharma is the pharmaceutical division of Angelini Group. The Group started almost 100 years ago as a small pharmaceutical laboratory, and over the years has grown into a leading international group in healthcare, present in Pharmaceuticals and Mass-Market.
Seit über 200 Jahren verhelfen wir Menschen zu einem gesünderen Leben und glücklicheren Zuhause. Wir setzen uns unermüdlich dafür ein, dass der Zugang zu Hygiene, gesundheitlicher Versorgung und gesunder Ernährung kein Privileg, sondern ein Grundrecht für jeden Menschen ist. Zu unserem Portfolio gehören bekannte Marken wie Air Wick, Calgon, Cillit Bang, Clearasil, Dobendan, Durex, Finish, Gaviscon, Nurofen, Sagrotan, Vanish, Veet und Woolite.
Takeda Pharmaceutical is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI) also investments in Plasma-Derived Therapies and Vaccines.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience and Gastroenterology. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term sustainable perspective.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.
As part of our company’s evolution, we are updating our branding and uniting our businesses under the Johnson & Johnson name to demonstrate our collective power in healthcare.
Chiesi USA, Inc. is a specialty pharmaceutical company focused on commercialization of products for the hospital, rare disease and target office-based specialties. Our employees take an entrepreneurial approach to meet the evolving needs of our customers and patients. As a Public Benefit Corporation, Chiesi USA is committed to operating as a good corporate citizen; positively impacting communities in which we live and serve.